Mondelez International, Inc.
At today's price, Mondelez International, Inc. (MDLZ) is priced for +9.7% growth. boothcheck doesn't publish a fair value or a price target; it shows what the price assumes, so you can judge whether that bar is too high. Built from SEC EDGAR filings.
Mondelez is a global snacking company built on Biscuits and Baked Snacks (about 48% of revenue), Chocolate (33%), and Gum and Candy (11%), with brands like Oreo, Cadbury, and Milka. The decisive number right now is the cocoa bill: record cocoa costs cut Q1 2026 adjusted operating income about 19% at constant currency even as revenue grew. The franchise kept pricing through it. Net revenue rose 8.2% to $10.1 billion (organic up 3.0%), driven by higher net pricing, with strength in Europe, India,
Is MDLZ overvalued? See what's priced in →
1,847 institutional managers reported holding MDLZ in 13F filings for the quarter ended 2026-03-31. Together they hold about 79% of the company; the top 10 hold 43%. 182 opened new positions that quarter. Held by Vanguard Group, BlackRock, State Street, among others. On the short side, 32.8M shares were sold short as of the 2026-06-15 count, about 3% of shares outstanding (4.3 days of typical volume to cover).
Quarterly 13F filings arrive up to 45 days after quarter end, so the picture is never current (filed through 2026-05-29). Nothing here is investment advice.
MDLZ has cut its share count 8.8% over the past five years, spending $8.98B on repurchases. It pays a dividend, and has paid one every year in our records (18 and counting), raised 12 years straight; the current rate is $1.94 a share annually. Cash returned over the past three years: $6.58B in dividends and $5.76B in repurchases.
Share counts are split-adjusted; repurchase totals are gross of share issuance. Nothing here is investment advice.
No open-market insider buys on file at MDLZ over the trailing three years. Absence is a fact about the company, not a signal. 21 officers and directors are on file.
Code P open-market purchases from SEC Form 4 filings, non-derivative, excluding scheduled 10b5-1 plans. Nothing here is investment advice.
MDLZ's recent reports: the day-one move, then what the following quarter actually did.
| report | day one | next quarter |
|---|---|---|
| 2023-07-28 | +1.9% | -7.5% |
| 2023-11-02 | +2.7% | +7.8% |
| 2024-02-03 | +0.4% | -11.6% |
| 2024-05-01 | -1.6% | -6.2% |
Day-one is the close-to-close move around the filing. Nothing here is investment advice.
MDLZ's latest 8-K filings: 2026-06-18 (items 5.02); 2026-05-26 (items 5.07); 2026-04-28 (items 2.02, 9.01); 2026-02-18 (items 1.01, 1.02, 2.03, 9.01); 2026-02-03 (items 2.02, 9.01).
Item codes are the SEC's own classification of what each report discloses. Nothing here is investment advice.
Last analyzed: July 3, 2026
Each week boothcheck ranks the stocks whose prices are betting on the most. Read the most stretched bets archive →
boothcheck is also on Android. Get the app on Google Play →
For informational and research purposes only. Not investment advice. Not a recommendation to buy, sell, or hold any security. boothcheck is not a registered investment adviser. Past performance does not guarantee future results.